The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026. Anticoagulants are widely used across the healthcare industry for the treatment of several cardiovascular and health-related disorders. They are effectively used to treat blood clots avoid blockage of blood flow that is caused due to these drugs.
Highlights of the Report:
- In-depth analysis of various insights, namely, Anticoagulants Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Anticoagulants Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807
Key Players Operating in The Anticoagulants Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Bayer AG
- Janssen Pharmaceuticals, Inc.
- Eisai Co., Ltd.
- Other Prominent Players
Increasing Number of Company Mergers Will Aid Market Growth
Several growth stimulating factors have been analyzed and discussed in detail. Among all factors, the increasing number of company mergers have had the highest impact on the market. In February 2019, Novartis AG and Blackstone’s LifeSciences announced the launch of Anthos Therapeutics. The company is aiming for the research and development of drugs that include anticoagulants as a prime pipeline candidate. Increasing number of drug approvals is another factor that has constituted an increase in the global anticoagulants market size in recent years. Janssen Pharmaceuticals’ Rivaroxaban is an example of a recent drug approval that has had a direct impact on the market.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anticoagulants-market-101807
North America to Emerge Dominant; High Prevalence of Cardiovascular Disease to Create Several Growth Opportunities
The market is segmented on the basis of regional demographics into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The high prevalence of cardiovascular disease, coupled with the increasing emphasis on the research and development of new drugs will open up a huge potential for the companies operating in the market in this market. As of 2018, the market in North America was worth USD 10.10 billion. Besides North America, Europe will witness significant growth in the coming years, owing to the high incidence of deaths caused due to cardiovascular disease in several countries across this region. The high demand for anticoagulants in emerging countries such as Germany, France, and UK will have a positive influence on the growth of the market in this region.
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Major Cardiovascular Diseases by Key Countries
- Overview of Novel Oral Anticoagulants (NOACs)
- Pipeline Analysis
- Key Industry Developments Such as Mergers & Acquisitions
- New Product Launches
- Regulatory Scenario in Key Countries
- Reimbursement Scenario by Key Countries
- Global Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Disease Indication
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Atrial Fibrillation
- Heart Attacks
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Injectable
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market Analysis, Insights and Forecast – By Country
- North America
- Europe
- Asia pacific
- Latin America
- Middle East & Africa
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anticoagulants-market-101807
Report Focus:
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Anticoagulants Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Anticoagulants Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
- User Also Search For- side effects of anticoagulants, newer anticoagulants, lupus anticoagulants, anticoagulants vs antiplatelets
KEY QUESTIONS ANSWERED:
- What is the market size and growth rate of the global and regional market by various segments?
- What is the market size and growth rate of the market for selective countries?
- Which region or sub-segment is expected to drive the market in the forecast period?
- What Factors are estimated to drive and restrain the Anticoagulants Market growth?
- What are the key technological and market trends shaping the market?
- What are the key opportunities in the market?
- What are the key companies operating in the market?
- Which company accounted for the highest market share?
Related Reports:
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
